These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 13837199)

  • 1. The circul atory effects of bretylium tosylate and guanethidine.
    TAYLOR SH; DONALD KW
    Lancet; 1960 Aug; 2(7147):389-94. PubMed ID: 13837199
    [No Abstract]   [Full Text] [Related]  

  • 2. The initial pressor actions of bretylium tosylate and guanethidine sulfate and their relation to release of catecholamines.
    GILLIS CN; NASH CW
    J Pharmacol Exp Ther; 1961 Oct; 134():1-7. PubMed ID: 13898659
    [No Abstract]   [Full Text] [Related]  

  • 3. Bretylium and guanethidine: two new drugs producing specific blockade of the sympathetic nervous system.
    FREIS ED
    Heart Bull; 1960; 9():88-9. PubMed ID: 13824829
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral and corticocerebral reactions to adrenergic mediators under the effect of bretylium and guanethidine].
    MINZ B; NOEL P
    C R Seances Soc Biol Fil; 1962; 156():593-7. PubMed ID: 14474375
    [No Abstract]   [Full Text] [Related]  

  • 5. A new view of adrenergic nerve fibres, explaining the action of reserpine, bretylium, and guanethidine.
    BURN JH
    Br Med J; 1961 Jun; 1(5240):1623-7. PubMed ID: 13689141
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of bretylium tosylate with guanethidine in the treatment of severe hypertension.
    EVANSON JM; SEARS HT
    Lancet; 1960 Aug; 2(7147):387-9. PubMed ID: 13821025
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on a new hypotensive agent: bretylium tosylate.
    GENEST J; DUFAULT G; PIGEON G; DAVIGNON J; BIRON P; TRUDEL J
    Can Med Assoc J; 1960 Apr; 82(17):872-7. PubMed ID: 13827287
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of guanethidine and bretylium on the liberation of pyrocatecholamines].
    PHILIPPU A; SCHUEMANN HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 243():26-35. PubMed ID: 14486205
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the acute circulatory effects of guanethidine and bretylium.
    GAFFNEY TE; BRAUNWALD E; COOPER T
    Circ Res; 1962 Jan; 10():83-8. PubMed ID: 13896180
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of bretylium tosylate on renal function in the course of arterial hypertension].
    ZUCCHELLI P; DALMASTRI G
    G Clin Med; 1961 Jan; 42():1-14. PubMed ID: 13788864
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of brachial arterial infusion of bretylium tosylate on hand blood flow.
    FRENCH EB; MATTHEWS MB
    Clin Sci; 1961 Oct; 21():151-5. PubMed ID: 13895014
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of bretylium tosylate on blood-pressure, cardiac output, and renal function in hypertension.
    DOYLE AE; FRASER JR; SMITH PK
    Br Med J; 1960 Aug; 2(5196):422-5. PubMed ID: 13817928
    [No Abstract]   [Full Text] [Related]  

  • 13. Some pharmacological actions of bretylium and guanethidine.
    VERNIKOS-DANELLIS J; ZAIMIS E
    Lancet; 1960 Oct; 2(7154):787-8. PubMed ID: 13780968
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of guanethidine and bretylium on the dog heart-lung preparation.
    GAFFNEY TE
    Circ Res; 1961 Jan; 9():83-8. PubMed ID: 13702899
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural requirements for bretylium and guanethidine-like activity.
    COSTA E; KUNTZMAN R; GESSA GL; BRODIE BB
    Life Sci (1962); 1962 Mar; 1():75-80. PubMed ID: 13881572
    [No Abstract]   [Full Text] [Related]  

  • 16. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.
    HERTTING G; AXELROD J; PATRICK RW
    Br J Pharmacol Chemother; 1962 Feb; 18(1):161-6. PubMed ID: 14036196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1962 Aug; 19(1):13-41. PubMed ID: 13871863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supersensitivity of salivary glands following treatment with bretylium or guanethidine.
    EMMELIN N; ENGSTROM J
    Br J Pharmacol Chemother; 1961 Jun; 16(3):315-9. PubMed ID: 13726638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of bretylium and guanethidine at the neuromuscular junction.
    DIXIT BN; GULATI OD; GOKHALE SD
    Br J Pharmacol Chemother; 1961 Dec; 17(3):372-9. PubMed ID: 13886626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic neurone-blocking agents related to choline 2, 6-xylyl ether bromide (TM 10), bretylium and guanethidine.
    BOURA AL; COPP FC; GREEN AF; HODSON HF; RUFFELL GK; SIM MF; WALTON E; GRIVSKY EM
    Nature; 1961 Sep; 191():1312-3. PubMed ID: 13871861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.